17:08 EST Lucid Diagnostics (LUCD) files $175M mixed securities shelf
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LUCD:
- Lucid Diagnostics: Buy Rating Backed by Strong Growth, Financial Stability, and Strategic Expansion
- Lucid Diagnostics: Positive Indicators and Medicare Reimbursement Potential Support Buy Rating
- Positive Outlook for Lucid Diagnostics: Buy Rating Affirmed Amid Growth in EsoGuard Test Volumes and Strong Financial Management
- Lucid Diagnostics Reports Q3 2025 Financial Results
- Lucid Diagnostics’ Earnings Call: Strategic Wins Amid Challenges